Dr. Denis Fedorenko

The Leading Hematologist of Russia, Doctor of Medical Sciences,
Professor of the Department of Hematology and Cellular Therapy
The Main Directions of Work
  • Treatment of diseases of the blood system with the use of modern technologies, incl. bone marrow transplantation / peripheral hematopoietic stem cells, high-dose chemotherapy, immunotherapy of oncohematological diseases (lymphomas, leukemia)

  • High-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis and other systemic autoimmune diseases

  • Risk-adapted therapy of leukemia and lymphoma
Professional Experience
1993-1999 - Military Medical Academy named after S.M. Kirov.

1999-2000 - Internship on the specialty "Internal Diseases".

2001-2004 - Department of Hematology and Clinical Immunology of the Military Medical Academy.
Professor of Medical Science
Author of more than 200 scientific papers and 1 invention:

"A method for treating multiple sclerosis and other systemic autoimmune diseases"

patent No. 2600160
HSCT Treatment Coordinator
Coordinator of a program of high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis and other systemic autoimmune diseases.
Treatment Program "Quality of Life"
A participant in international programs for the study of quality of life and symptoms in oncohematological patients on the background of various treatment programs.
Efficacy and toxicity study of high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation in multiple sclerosis and other systemic autoimmune diseases.
Scientific Researches
Studying of the features of mobilization and conditioning using high-dose immunosuppressive therapy with autologous transplantation of hematopoietic stem cells in patients with multiple sclerosis and other systemic autoimmune diseases
Candidate Dissertation
"Syndrome of generalized weakness in patients with certain systemic diseases of connective tissue."
Doctoral Dissertation
"Principles of assessing the effectiveness of autologous transplantation of hematopoietic stem cells in patients with lymphomas and multiple sclerosis."
Membership in World Associations
ASH - Member of the American Association of Hematology

EHA
- Member of the European Hematology Association

ISQOL
- Member of the International Society for the Study of Quality of Life
- We carefully weigh risk and benefits of transplantation in every individual case. Detailed examination always precedes the final decision about the appropriateness of high-dose immunosuppressive therapy with hematopoietic stem cell transplantation.
Dr. D.Fedorenko

№1 on MS

THE LARGEST SINGLE CENTER EXPERIENCE IN THE WORLD
10
Years
Our accumulated experience
is 10 years of follow-up applying stem cell transplantation to the treatment of autoimmune diseases.
800
Patients
More than eight hundred patients underwent this therapy with autologous hematopoietic stem cell transplantation in our Department.
75-95%
Efficacy
The rate of MS stabilization of our patients is about 75-90% after transplantation and 90-95% during follow-up period for RRMS
WHAT LEADS TO CHOOSE US
Ask your self:
Wanted to be treated with the most effective and safe method of HSCT?
The method allows to completely eliminate groups of autoimmune cells
and effects the nature of their formation.
You were refused in other places due to the severity of illness?
The accumulated experience and technologies allows us
to successfully cope with SPMS and PPMS, as well as RRMS
Wondering about how much will the trip cost you in total?
The contract amount includes everything you need, simply buy tickets and don't forget your passport.
You were offered a place in a very long waiting list?
You do not have to wait years for transplantation.
And the therapy itself does not require any special preparation.
Worrying about the accommodation and quality of medical care?
The treatment goes stationary, under 24/7 observation by the leading team of specialists, and takes place in the Department of the world-famous Multidisciplinary Medical-Surgical Center of Russia.
Complete our questionnaire to define, whether HSCT treatment - is acceptable for you and results would be approved.
Spend an hour of your time to complete our medical form, describes in details your previous treatment and past and current functional status.

Your completed medical questionnaire will be personally reviewed by
Dr. Denis Fedorenko, MD, PhD, and within only one week he will respond to you by e-mail.